Century Therapeutics (IPSC) SVP Carr Douglas Sells Shares

What Happened
Carr Douglas, SVP Finance & Operations at Century Therapeutics (IPSC), sold 254 shares on 2026-09-08 at $2.05 per share, resulting in proceeds of $521. This was a sale (not a purchase) and, per the filing footnote, was executed to satisfy tax withholding on vested restricted stock units.

Key Details

• Transaction date and price: 2026-09-08 — 254 shares sold at $2.05 each.
• Total proceeds: $521.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnote: The sale was automatic to cover tax withholding obligations related to RSU vesting; not at the Reporting Person’s discretion (Footnote F1).
• Filing date/timeliness: Form 4 filed 2026-09-09 (covers the 2026-09-08 transaction) — appears to be filed promptly.

Context
Sales made solely to cover tax withholding on vested awards are routine and do not necessarily signal a change in insider sentiment. The transaction value here is small ($521), so it’s unlikely to be material to investor views by itself. For a fuller picture, look for additional insider trades, ownership levels, and company fundamentals.